Madrigal Pharmaceuticals Inc (MDGL)
Depreciation & Amortization
$1.52M
TTM · Period ending: · USD
MDGL Depreciation & Amortization
Latest reported$1.52Mperiod ending
Latest reported$1.52Mperiod ending
MDGL TTM Depreciation & Amortization ($3.35M → $1.52M)
TTM Depreciation & Amortization
High-resolution chart · PNG
MDGL depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 1,517,000 | |
| 1,513,000 | |
| 1,506,000 | |
| 1,477,000 | |
| 1,417,000 | |
| 1,307,000 | |
| 1,096,000 | |
| 875,000 | |
| 712,000 | |
| 571,000 | |
| 527,000 | |
| 514,000 | |
| 500,000 | |
| 484,000 | |
| 467,000 | |
| 444,000 | |
| 420,000 | |
| 399,000 | |
| 405,000 | |
| 415,000 | |
| 433,000 | |
| 459,000 | |
| 471,000 | |
| 383,000 | |
| 296,000 | |
| 209,000 | |
| 112,000 | |
| 109,000 | |
| 105,000 | |
| 101,000 | |
| 96,000 | |
| 131,000 | |
| 116,000 | |
| 100,000 | |
| 77,039 | |
| -124,961 | |
| 11,857,039 | |
| 11,945,039 | |
| 11,991,000 | |
| 12,292,000 | |
| 467,000 | |
| 539,000 | |
| 662,000 | |
| 672,000 | |
| 673,000 | |
| 674,000 | |
| 673,000 | |
| 647,000 | |
| 628,000 | |
| 584,000 | |
| 516,000 | |
| 488,000 | |
| 510,000 | |
| 608,000 | |
| 738,000 | |
| 914,000 | |
| 1,094,000 | |
| 1,255,000 | |
| 1,464,000 | |
| 1,636,000 | |
| 1,759,000 | |
| 1,857,000 | |
| 1,933,000 | |
| 1,985,000 | |
| 2,116,000 | |
| 2,285,000 | |
| 2,463,000 | |
| 2,630,000 | |
| 2,755,000 | |
| 2,732,000 | |
| 2,717,000 | |
| 2,914,000 | |
| 3,011,000 | |
| 3,231,000 | |
| 3,351,000 | |
| 3,299,000 | |
| 2,903,000 |